1. Home
  2. APPN vs GHRS Comparison

APPN vs GHRS Comparison

Compare APPN & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$30.38

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$30.50

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPN
GHRS
Founded
1999
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
APPN
GHRS
Price
$30.38
$30.50
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$29.80
$41.38
AVG Volume (30 Days)
770.1K
296.3K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
101.59
N/A
EPS
N/A
N/A
Revenue
$226,743,000.00
N/A
Revenue This Year
$13.79
N/A
Revenue Next Year
$10.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.29
N/A
52 Week Low
$18.63
$11.32
52 Week High
$46.06
$31.00

Technical Indicators

Market Signals
Indicator
APPN
GHRS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
APPN
GHRS

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its Domestic operations, and also has its presence Internationally.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: